SARS Commissioner Profile

Edward Kieswetter

Commissioner of SARS

Date of Birth: 6 November 1958
Age: 63  

Twitter Handle: @edkieswetter

Edward Kieswetter


Edward re-joined as SARS Commissioner on 1 May 2019. He had formerly served as the founding Group Executive of the SARS Large Business Centre and High Nett Worth Unit, SARS Chief Operating Officer and Deputy Commissioner during the period 2004 to 2009. From 2010 to 2016, he was the Group Chief Executive for the Alexander Forbes Group Holdings where after a successful turnaround, the company was listed on the JSE. Edward also held senior executive roles at FirstRand Banking Group and Eskom. Most recently he managed his own investments and served on various boards which amongst others included NE: Transnet, Chair: Technology Innovation Agency and Lead Independent: Shoprite Holdings.

Edward’s qualifications include a Master of Commerce in SA & International Tax Law (Cum Laude) from North-West University, an MBA from Henley Business School (UK), a Master of Science in Education from the University of Western Cape, a Honours degree in Mathematics and Science Education, also from the University of Western Cape, as well as a National Diploma in Electrical Engineering from the Cape Peninsula University of Technology. In addition Edward was awarded the prestigious African American Scholarship and an academic appointment as an Associate in Education at Harvard University, USA.

He is the recipient of several awards including a Lifetime Achievement Award for Excellence in Management in 2017 from SAPSO, Finalist in the All Africa Business Awards 2016, ACO Dealmaker of the Year, 2015, and SA Boss of the Year, 1999.

He serves as a Visiting Professor at the Da Vinci Institute as well as Free State University, Member of Ahmed Kathrada Foundation and remains involved as a Social Activist.

Table of Contents

Last Updated:

What is your experience of the website? Did you find what you were looking for?
Click here to answer our one-minute survey – Tell us what you think of the SARS website.

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print